Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | Mr. Kyle PilkingtonChief Legal Officer | -25,00k | 30,01k | Automatic Disposition | 1,20 | 289,90k | -7,94% |
| 2026-04-14 | Ms. Jing Liu NealisInitié | -36,15k | 39,76k | Sale to Issuer | 1,10 | 1,47M | -2,40% |
| 2026-04-14 | Dr. Qichao HuFounder, Chairman & CEO | -133,30k | 146,63k | Sale to Issuer | 1,10 | 1,95M | -6,39% |
| 2026-04-14 | Mr. Kyle PilkingtonChief Legal Officer | -25,19k | 27,70k | Sale to Issuer | 1,10 | 314,90k | -7,41% |
| 2026-04-14 | Dr. Hong GanChief Science Officer | -32,14k | 35,35k | Sale to Issuer | 1,10 | 557,00k | -5,46% |
| 2026-03-27 | Ms. Jing Liu NealisInitié | -163,97k | 161,89k | Sale to Issuer | 0,99 | 1,44M | -10,25% |
| 2026-03-27 | Mr. Kyle PilkingtonChief Legal Officer | -60,45k | 59,68k | Sale to Issuer | 0,99 | 284,30k | -17,54% |
| 2026-03-27 | Dr. Kang XuCTO | -39,59k | 39,09k | Sale to Issuer | 0,99 | 263,74k | -13,05% |
| 2026-03-27 | Dr. Hong GanChief Science Officer | -74,68k | 73,73k | Sale to Issuer | 0,99 | 519,40k | -12,57% |
| 2026-03-27 | Dr. Qichao HuFounder, Chairman & CEO | -310,45k | 306,50k | Sale to Issuer | 0,99 | 1,81M | -14,67% |
| 2026-03-09 | Mr. Kyle PilkingtonChief Legal Officer | -25,00k | 30,00k | Automatic Disposition | 1,20 | 211,42k | -10,57% |
| 2026-02-09 | Mr. Kyle PilkingtonChief Legal Officer | -56,07k | 111,59k | Sale to Issuer | 1,99 | 236,42k | -19,17% |
| 2026-02-09 | Dr. Hong GanChief Science Officer | -63,29k | 125,95k | Sale to Issuer | 1,99 | 427,42k | -12,90% |
| 2026-02-06 | Dr. Kang XuCTO | -35,06k | 65,92k | Sale to Issuer | 1,88 | 220,00k | -13,75% |
| 2026-02-09 | Dr. Qichao HuFounder, Chairman & CEO | -267,93k | 533,19k | Sale to Issuer | 1,99 | 1,42M | -15,90% |
| 2026-02-09 | Ms. Jing Liu NealisInitié | -110,23k | 219,36k | Sale to Issuer | 1,99 | 1,28M | -7,91% |
| 2026-01-22 | Dr. Hong GanChief Science Officer | -250,00k | 584,71k | Derivative Exercise and Sale | 0,16 - 2,50 | 401,06k | - |
| 2025-12-15 | Dr. Hong GanChief Science Officer | -100,00k | 182,82k | Derivative Exercise and Sale | 0,15 - 1,98 | 401,06k | - |
| 2025-11-17 | Dr. Hong GanChief Science Officer | -150,00k | 262,73k | Derivative Exercise and Sale | 0,15 - 1,90 | 401,06k | - |
| 2025-09-03 | Dr. Kang XuCTO | -39,24k | 42,77k | Sale to Issuer | 1,09 | 184,44k | -17,54% |
| 2025-08-18 | Ms. Jing Liu NealisInitié | -15,69k | 16,95k | Sale to Issuer | 1,08 | 1,19M | -1,30% |
| 2025-08-08 | Mr. Kyle PilkingtonChief Legal Officer | -5,45k | 6,16k | Sale to Issuer | 1,13 | 179,50k | -2,95% |
| 2025-07-16 | Ms. Jing Liu NealisInitié | -15,69k | 15,44k | Sale to Issuer | 0,98 | 1,21M | -1,29% |
| 2025-06-16 | Ms. Jing Liu NealisInitié | -15,69k | 15,04k | Sale to Issuer | 0,96 | 1,22M | -1,27% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
